I have been diagnosed with Mild Cognitive Impairment. Have been searching for a support group that will help me. I am having a hard time dealing with the memory loss, forgetfulness, carelessness, being in the middle of a sentence and can't think of a word. I am only 59, the doc is calling it Early Onset. I know there must be others out there going through what I am. I need to talk.
Added 27 Jun 2011:
I am on Arecept and Namenda. Does anyone know what these two meds do to the brain?
Namenda is used to treat moderate to severe dementia caused by Alzheimer's disease. It is not a cure for Alzheimer's, but can help slow down the worsening of Alzheimer. Namenda is classified as an NMDA receptor antagonist. "NMDA" stands for N-methyl-D-asparate. It is thought that some of the symptoms of Alzheimer's may be related to changes in NMDA receptors that allow for abnormal, excessive excitation of the receptors by glutamate (a neurotransmitter brain chemical). Namenda works by binding to the NMDA receptor and preventing excessive excitation by glutamate. Currently, there are no other Alzheimer's medications that work in this way. https://www.drugs.com/namenda.html Aricept is used to treat the symptoms of dementia due to Alzheimer's disease. It belongs to a group of medications known as acetylcholinesterase inhibitors.
It works by stopping a specific enzyme (known as acetylcholinesterase) from breaking down acetylcholine in the brain. Acetylcholine is a chemical that aids in many brain functions, including memory, attention, reason, and language. https://www.drugs.com/aricept.html
Subscribe to receive email notifications whenever new articles are published.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated Dec 6th, 2018), Cerner Multum™ (updated Dec 7th, 2018), Wolters Kluwer™ (updated Dec 5th, 2018) and others. To view content sources and attributions, please refer to our editorial policy.